Telehealth

With $15M from top UAE families, TruDoc is scaling its 'hospital-at-home' model, signaling a major shift in how the GCC delivers critical care.

A NY startup is using quantum computing and AI to fight aging at its source. Can Allosteric Bioscience's high-tech approach unlock a longer, healthier life?

With strong revenue growth and critical FDA decisions on the horizon, MannKind's leadership prepares to outline its vision for investors in Miami.

A new partnership turns your smartphone into a motion lab, creating a powerful loop to assess and correct the root causes of chronic pain from home.

With four new partners and a zero-markup model, Harrison.ai's Open Platform aims to democratize access to powerful medical AI tools for providers globally.

Beyond an industry award, TimelyCare's success reveals how measurable outcomes and virtual care are becoming essential for student retention and well-being.

The D.C. transplant institute surpasses a historic milestone, pioneering new tech and giving thousands a second chance at life amid a national organ shortage.

A 10-year, $25M program created 108 palliative care leaders. A new report reveals its impact on a field facing a critical workforce and access crisis.

A successful Puerto Rico pilot shows how cellular RPM and culturally-aware care can control hypertension, paving the way for a national FQHC rollout.

A new partnership gives thousands of young athletes in Las Vegas free recovery tech while a unique manufacturing model boosts the local economy.

A new insurer contract expands Rocket Doctor's telehealth network to millions of New Yorkers on Medicaid and Medicare, aiming to close critical care gaps.

A new partnership fuses marketing muscle with AI tech to launch a health platform in China, but it faces major regulatory and privacy hurdles.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

A €21.5M consortium is launching clinical trials for AI that assists in brain and cancer surgery, aiming to ease a critical European doctor shortage.

Post-listing, the Swiss HealthTech firm pushes for US market expansion and European reimbursement, streamlining its focus on AI-powered brain health.

With soaring revenue and new EU approval, Senseonics is taking control of its sales, but rising costs raise questions about its path to profitability.

Peli BioThermal and Polar Group partner to upgrade Brazil's pharma logistics, tackling a booming market and ensuring safer delivery of advanced medicines.

A federal policy loophole is diverting billions from struggling rural providers to wealthy urban hospitals, threatening care for millions of Americans.

As AI reshapes medicine, Seoul prepares to host global experts to explore its vast potential and critical challenges in healthcare and medical tourism.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?